Charles River Labs 8-K Filing Insights: Key Updates on January 14, 2025
Here are the key pieces of information extracted from the provided financial report section:
- Filing Information:
- Filing Type: 8-K
- Filing Date: January 14, 2025
- Entity Name: Charles River Laboratories International, Inc.
- CIK Number: 0001100682
- Company Details:
- State of Incorporation: Delaware (DE)
- SEC Central Index Key (CIK): 0001100682
- IRS Employer Identification Number (EIN): 06-1397316
- Address: 251 Ballardvale Street, Wilmington, MA 01887
- Phone Number: 781-222-6000
- Stock Information:
- Class of Stock: Common stock
- Par Value: $0.01
- Ticker Symbol: CRL
- Exchange: NYSE
- Reporting Period:
- Report Start Date: January 14, 2025
- Report End Date: January 14, 2025
Insights:
- The report indicates that Charles River Laboratories is filing an 8-K, which typically provides current information that may be of importance to shareholders. This could involve events like acquisitions, changes in management, or other significant corporate actions.
- The filing date aligns with the reporting period, suggesting that this may be a timely disclosure of an event occurring on that date.
- The company is publicly traded on the NYSE under the ticker CRL, which can be relevant for investors monitoring stock performance and market activity related to the company.
This information is critical for stakeholders, including investors, analysts, and regulators, to understand the company's current status and any significant developments that may impact its operations or stock performance.